Health
NCDC Issues Public Health Advisory On Human Metapneumovirus (HMPV)
There is no specific antiviral treatment or vaccine for HMPV.
The Nigeria Centre for Disease Control and Prevention (NCDC) has issued the following Public Health Advisory on Human Metapneumovirus (HMPV) Awareness, Preparedness, and Prevention.
The document released by, Dr. Jide Idris, the Director – GeneralNigeria Centre for Disease Control and Prevention, said :
” NCDC is committed to safeguarding the health of all Nigerians. In response to recent reports of increased Human Metapneumovirus (HMPV) activity in China and other affected regions, as well as growing public interest in the matter, the NCDC in collaboration with the Federal Ministry of Health and Social Welfare is closely monitoring global developments.
We aim to provide timely, accurate information and guidance to keep the Nigerian public informed and prepared. Global situation update.
It is important to note that the rumor circulating about the World Health Organization (WHO) declaring HMPV a Public Health Emergency of International Concern (PHEIC) is false and should be disregarded.
The WHO has not made such a declaration. Recent reports indicate a significant rise in Human Metapneumovirus (HMPV) cases in China, as well as increased respiratory infections linked to HMPV in countries such as the United Kingdom (UK), France, and Germany, particularly during the winter season.
The UK Health Security Agency (UKHSA) has highlighted a notable rise in hospital admissions due to HMPV-related complications, especially among children under five and older adults in care homes.
This trend emphasizes the need for heightened preparedness and vigilance.
Current Situation in Nigeria
Nigeria operates a National Influenza Sentinel Surveillance (NISS) system, comprising sentinel sites distributed across the six geopolitical zones of the country.
These sites, which include tertiary and secondary health facilities, monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).
As of January 6, 2025, data from this surveillance system does not indicate any unusual increase in respiratory infections, including those caused by Human Metapneumovirus (HMPV).
However, given the global trends in HMPV cases, the Nigeria Centre for Disease Control and Prevention (NCDC) is proactively implementing measures to strengthen the country’s preparedness and response capacity.
NCDC Preparedness Measures
The NCDC is closely monitoring the situation and has implemented the following actions to ensure public health safety:
1. Dynamic Risk Assessment
On January 6, 2025, the Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA), conducted a dynamic risk assessment for Human Metapneumovirus (HMPV).
The assessment classified the risk of HMPV for Nigeria as moderate.
This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts.
2. Public Health Advisory:
Issued this advisory to provide Nigerians with up-to-date information on preparedness actions and preventive measures.
3. Point of Entry (POE):
The Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with Port Health Authorities, is taking proactive steps to ensure robust preparedness at all international points of entry (PoEs) in response to the dynamic risk assessment for Human Metapneumovirus (HMPV).
These measures are designed to mitigate the potential risk of HMPV transmission through international travel. Key actions include
▪︎ Conducting a comprehensive situation analysis at all international PoEs to assess current readiness levels.
▪︎ An Entry Implementation Protocol on HMPV, approved by the Honourable Minister of Health and Social Welfare, is being developed and will be distributed to all points of entry to guide response activities.
▪︎ In addition, quarantine facilities are being identified and prepared to manage any suspected or confirmed cases if required.
▪︎ Infection Prevention and Control (IPC) materials are being deployed to PoEs to ensure adherence to hygiene and safety protocols.
▪︎ Information, Education, and Communication (IEC) materials are being developed and distributed to raise awareness and provide clear guidelines for frontline staff and travelers at PoEs.
4. Enhanced Surveillance and Laboratory Diagnosis:
The National Influenza Sentinel Surveillance (NISS) sites across the six geopolitical zones monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).
This platform, which is already testing for COVID-19, will now also start testing for HMPV. Provisions will be made to increase the number of tests conducted.
Additionally, laboratories in states with international airports will be supported to enable them to test for HMPV.
5. Infection Prevention and Control (IPC):
Advisories have been issued to hospitals nationwide on enhanced IPC practices, including proper hand hygiene, environmental cleaning, respiratory hygiene, and cough etiquette.
All health facilities are required to identify an appropriate isolation room where cases can be quickly isolated while receiving care.
6. Case Management Preparedness:
Collaborating with state governments and healthcare facilities to provide training for healthcare workers to ensure adequate case management teams are in place and ready to respond if needed.
This will ensure that healthcare workers are able to provide appropriate care and maintain a high index of suspicion. Supportive care and an emphasis on a high index of suspicion are crucial.
We are requesting state governments to activate their treatment centers or isolation centers to ensure they are prepared to manage cases appropriately.
7. Stockpiling of Medical Countermeasures:
Relevant materials such as PPEs (face masks, hand gloves, hand hygiene supplies, and other essential IPC items) have been stockpiled for rapid deployment if required.
Additionally, laboratory consumables, reagents, and other necessary supplies have also been stockpiled to ensure readiness.
Risk Communication and Community Engagement:Engaging with the public through clear and accurate messages to address concerns, dispel misinformation, and encourage appropriate health-seeking behaviors.
We work in close collaboration with state risk communication and community engagement pillars, health educators, and other trusted voices, such as the media.
These efforts reflect NCDC’s commitment to proactive coordination and response at all levels of public health.
Public Advisory What is HMPV?
Human Metapneumovirus (HMPV) is a respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in:
• Young children •
Older adults
• Individuals with weakened immune systems
There is no specific antiviral treatment or vaccine for HMPV.
Supportive care, such as rest, hydration, and fever management, remains the primary approach to recovery.
Symptoms
• Cough
• Fever
• Nasal congestion
• Shortness of breath
• Wheezing
• Bronchitis or pneumonia (in vulnerable populations such as very young children, older people, patients with low immunity such and those on cancer treatment, uncontrolled diabetes etc).
The incubation period is 3-5 days after exposure, and infections typically resolve within 2-5 days with supportive care.
We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.
However, high-risk populations may experience complications.
Transmission HMPV spreads through:
• Respiratory droplets from coughing and sneezing
• Close personal contact (e.g., touching or shaking hands)
• Touching contaminated surfaces and then touching the face.
Overcrowding and poor ventilation can lead to increased transmission, e.g., in congregate settings such as correctional centers and poorly managed IDPs.
Preventive Measures
To reduce the risk of HMPV infection, the public is advised to follow these preventive steps:
For the General Public:
• Hand Hygiene: Wash hands frequently with soap and water for at least 20 seconds.
• Respiratory Etiquette: Cover your mouth and nose with a tissue or elbow when coughing or sneezing. Cover your mouth an nose with face mask if you are experiencing flu like symptoms.
• Avoid Close Contact: Maintain distance from individuals showing symptoms of respiratory illness.
• Avoid overcrowded places.
• Disinfect Surfaces: Regularly clean and disinfect frequently touched objects and surfaces.
• Self-Isolation: Stay home if experiencing symptoms to prevent spreading the virus. As is correct parctice and seek medical care from appropriate sources.
Protecting Vulnerable Groups:
• Young children, older adults, and individuals with underlying health conditions such as people with chronic diseases such as diabetes, on cancer treatment, immunicompromised paients or those with low immunity should seek prompt medical attention if experiencing severe symptoms. Healthcare Guidance
For Healthcare Workers:
• Reinforce Infection Prevention and Control (IPC) measures in healthcare facilities.
• Enhance surveillance for acute respiratory infections and report unusual increases to the relevant authorities. Index of suspiciona nd enhanced
• Use appropriate PPE when attending to patients with respiratory symptoms.
• Educate patients on preventive measures and when to seek emergency medical care.
• Provide symptomatic care and promptly refer severe cases to specialist facilities.
Conclusion
The NCDC remains dedicated to protecting the health of Nigerians through continuous surveillance and prompt response to infectious diseases.
We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.
We also emphasize the importance of relying on verified information from the NCDC and WHO.
For emergencies, please contact the NCDC’s toll-free line at 6232 or email us at info@ncdc.gov.ng.
Follow us on our verified social media platforms for timely updates.
Together, we can protect our communities from respiratory infections and ensure a healthier Nigeria.
Contact Information • Toll-Free Number: 6232 • SMS: *** • WhatsApp: *** • Twitter: @NCDCGov • Facebook: @NCDCgov • Instagram: @NCDCgov
Health
Ebola: President Tinubu approves N10bn to strengthen NCDC preparedness
This follows the rapidly expanding outbreak that has already killed at least 349 people across the Democratic Republic of Congo and Uganda, with the World Health Organisation declaring it a Public Health Emergency of International Concern.
President Bola Tinubu has approved the immediate release of N10 billion to strengthen the operational preparedness of the Nigeria Centre for Disease Control and prevention and support critical national public health emergency response activities.
The President also established a Presidential Task Force on Ebola Virus Disease Preparedness and Control.
This follows the rapidly expanding outbreak that has already killed at least 349 people across the Democratic Republic of Congo and Uganda, with the World Health Organisation declaring it a Public Health Emergency of International Concern.
A statement by the Special Adviser to the President on Information and Strategy, Bayo Onanuga, said the task force would be chaired by the Chief of Staff to the President, Femi Gbajabiamila, with membership drawn from relevant ministries, departments and agencies .
The task force was constituted following a stakeholder meeting convened by Gbajabiamila to review Nigeria’s preparedness.
It was attended by representatives from the Ministry of Interior, the Federal Airports Authority of Nigeria, the Nigeria Immigration Service, the Nigerian Civil Aviation Authority and the Lagos State Government, among others.
Health
Senate passes bill to establish Malaria Elimination Agency
The bill, sponsored by Ned Nwoko, scaled third reading on Wednesday after the Senate considered and adopted the report of its Committee on Health (Secondary and Tertiary), chaired by Ipalibo Banigo.
The Senate has passed a bill seeking to establish a National Agency for Malaria Elimination saddled with the responsibility of preventing, controlling and ultimately eliminating malaria in Nigeria.
The bill, sponsored by Ned Nwoko, scaled third reading on Wednesday after the Senate considered and adopted the report of its Committee on Health (Secondary and Tertiary), chaired by Ipalibo Banigo.
Presenting the report on behalf of Banigo, Sampson Ekong said the proposed agency would serve as the central body responsible for coordinating national efforts aimed at preventing, controlling and ultimately eliminating malaria in Nigeria.
The Senate said the agency seeks to mark a shift in the country’s approach to malaria management from treatment-focused interventions to preventive and elimination strategies.
“The agency, when established, will help shift the country’s approach from curative measures to prevention and eventual elimination of malaria,” it stated.
(Source: The SUN)
Health
Cross River restores molecular laboratoy for TB, HIV, Mpox testing
This place is arranged to address issues of TB, HIV and other outbreaks. Mpox, Lassa fever and even Ebola-related surveillance can be handled here. Most of the essential services have now been restored,” he said.
Photo : Governor Bassey Otu of Cross River State
The Cross River State Government has announced that the molecular laboratory services at Dr. Lawrence Henshaw Memorial Hospital now conducts molecular testing for tuberculosis, HIV and Mpox while retaining the capacity to support surveillance and response efforts for emerging public health threats..
The Commissioner for Health, Dr. Egbe Ayuk, disclosed this on Tuesday during an inspection tour of the hospital alongside journalists in Calabar.
Ayuk said that the molecular laboratory, which serves as one of the state’s key public health surveillance centres, has resumed most of its essential functions following rehabilitation efforts supported by the state government and development partners.
“This place is arranged to address issues of TB, HIV and other outbreaks. Mpox, Lassa fever and even Ebola-related surveillance can be handled here. Most of the essential services have now been restored,” he said.
The commissioner explained that although the facility suffered extensive damage during the EndSARS unrest, significant progress has been made in rebuilding critical infrastructure and restoring laboratory operations.
-
News2 days agoCourt Voids ₦110bn N’Assembly Vehicles, Allowances
-
Business3 days agoSenate’s approval of Sugar – Sweetened Beverages Tax Bill, Shocking, says CPPE, Lobbying Reps for rejection
-
News3 days agoCourt Declares National Assembly’s N110bn SUV and Allowance Schemes Unlawful
-
News2 days agoFG Clears Five-Month Allowance Arrears for University Lecturers
-
News2 days agoLagos Begins 500-Tree Campaign to Tackle Extreme Heat
-
Politics2 days ago2027: Lagos APC picks Damilola as Hamzat ‘s Deputy Governor
-
Politics2 days agoNDC Declares Party Supremacy, Approves Code of Conduct Committee
-
Business2 days agoFederal Ministry of Finance Releases Funds to Over 1,240 Local Contractors
